Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
The surprising rise in global stock markets continued last week with a strong rally on Friday after US job figures were better than expected. The resilience of secondary equity markets, despite the Covid-19 pandemic, is a boost for those lining up equity block sales. -
The Austrian treasury has shaken up its funding outlook for the year as a result of the Covid-19 pandemic. Its new planned issuance total is almost double the previous target.
-
Marcus John, founder and chief executive of Sports Capital Advisors, tells GlobalCapital to expect a wave of insolvencies in national sport leagues but, he believes, sports with global appeal should fare better after lockdowns ease. Whether TV rights, a key source of revenue for major leagues, will be impacted remains unclear.
-
Hotelier Finance, a subsidiary of Hong Kong-based property company New World Development Co, is seeking consent to skip covenant tests until June next year as it deals with the impact of the Covid-19 pandemic on its business.
-
Burning Rock Biotech, a cancer detection and therapy company, has opened books for its up to $209.3m Nasdaq IPO following a hot week for Chinese listings in the US.
-
Bond buyers are showing interest in Peru’s nuevo sol denominated paper amid a sharp increase in EM risk appetite, according to the government’s public treasury director, even as Fitch downgraded the sovereign’s local currency debt rating last week.
